What will then be the expected EBITDA for FY19? Using 24% of revenue calc approximation, this will probably come in at around $120M EBITDA?
Ann: Mayne Pharma market update, page-2
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.30 |
Change
0.000(0.00%) |
Mkt cap ! $365.8M | |||
| Open | High | Low | Value | Volume |
| $4.30 | $4.39 | $4.23 | $1.190M | 275.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1673 | $4.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.31 | 598 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |